MINI FUTURE SHORT - DIASORIN Stock

Certificat

P1LHM8

NLBNPIT1LHM8

Market Closed - Borsa Italiana 19:03:21 2023-11-13 EST
50.1 ^EUR	-.--%

3 months	+2.45%
6 months	+38.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

DiaSorin receives clearance from US FDA for NxTAG panel	05-17	AN
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	05-16	PU
Funds move on DiaSorin and Leonardo on the Mib.	05-16	AN
Futures bullish; traders believe in Fed cut	05-16	AN

More news

Static data

Product type	Warrant Knock-Out con Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P1LHM8
ISIN	NLBNPIT1LHM8
Date issued	2023-01-09
Strike	14,024 €
Maturity	2025-12-19 (581 Days)
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	59.3 €
Lowest since issue	11.96 €
Spread	0.25 €
Spread %	0.49%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company